Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients

Pediatric Surgery International

Volumn 29, Issue 4, 2013, Pages 363-368

  Matsushita, Kohei ^a   Uchida, Keiichi ^a   Saigusa, Susumu ^a   Ide, Shozo ^a   Hashimoto, Kiyoshi ^a   Koike, Yuhki ^a   Otake, Kohei ^a   Inoue, Mikihiro ^a   Tanaka, Koji ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; NDRG1; Neuroblastoma; Prognostic marker

Indexed keywords

MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CELL MEMBRANE; CHILD; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; INFANT; MALE; MICRODISSECTION; N MYC DOWNSTREAM REGULATED GENE 1; NEUROBLASTOMA; NEUROBLASTOMA CELL; ONCOGENE C MYB; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME;

CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE;

EID: 84876294144     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-012-3248-6     Document Type: Article

References (26)

1. Esiashvili N, Anderson C, Katzenstein HM (2009) Neuroblastoma. Curr Probl Cancer 33:333-360
2. El-Sayed MI, Ali AM, Sayed HA et al (2010) Treatment results and prognostic factors of pediatric neuroblastoma: a retrospective study. Int Arch Med 3:37
3. Seeger RC, Brodeur GM, Sather H et al (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116
4. Schmidt ML, Lal A, Seeger RC et al (2005) Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J Clin Oncol 23:6474-6480
5. Nakagawara A, Kadomatsu K, Sato S et al (1990) Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Cancer Res 50:3043-3047
6. Chan HS, Gallie BL, DeBoer G et al (1997) MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res 3:1699-1706
7. Alaminos M, Gerald WL, Cheung NK (2005) Prognostic value of MYCN and ID2 overexpression in neuroblastoma. Pediatr Blood Cancer 45:909-915
8. Lachat P, Shaw P, Gebhard S et al (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118:399-408
9. Zhou RH, Kokame K, Tsukamoto Y et al (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73:86-97
10. Ellen TP, Ke Q, Zhang P et al (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29:2-8
11. Cangul H (2004) Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5:27
12. van Belzen N, Dinjens WN, Diesveld MP et al (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77:85-92
13. Chua MS, Sun H, Cheung ST et al (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20:76-83
14. Otake K, Uchida K, Tanaka K et al (2011) HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma. Pediatr Surg Int 27:217-223
15. Bijwaard KE, Aguilera NS, Monczak Y et al (2001) Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 47:195-201
16. Bandyopadhyay S, Pai SK, Gross SC et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63:1731-1736
17. Bandyopadhyay S, Pai SK, Hirota S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23:5675-5681
18. Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749-755
19. Li J, Kretzner L (2003) The growth-inhibitory NDRG1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc. Mol Cell Biochem 250:91-105
20. Sun B, Chu D, Li W et al (2009) Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J Neurooncol 94:213-219
21. Strzelczyk B, Szulc A, Rzepko R et al (2009) Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 16:1287-1294
22. Ando T, Ishiguro H, Kimura M et al (2006) Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 19:454-458
23. Segawa T, Nau ME, Xu LL et al (2002) Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21:8749-8758
24. Maruyama Y, Ono M, Kawahara A et al (2006) Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66:6233-6242
25. Song Y, Oda Y, Hori M et al (2010) N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Hum Pathol 41:214-222
26. Nishio S, Ushijima K, Tsuda N et al (2008) Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 264:36-43